Home Eurofins Panlabs Strengthens Drug Discovery Services With GE Healthcare's Cytiva Cardiomyocytes
 

Keywords :   


Eurofins Panlabs Strengthens Drug Discovery Services With GE Healthcare's Cytiva Cardiomyocytes

2013-07-31 08:51:41| drugdiscoveryonline News Articles

Eurofins Scientific (EUFI.PA), the world leader in food, environment and pharmaceutical products testing, has signed an agreement with GE Healthcare for the exclusive right to offer GE Healthcare’s Cytiva Cardiomyocytes for drug discovery and early development cardio toxicity screening services

Tags: services drug discovery drug discovery

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
03.07Lakamps research aims to use cattle genetics and microbiome information to make performance predictions
03.07Keep livestock safe during hurricane season with an emergency plan
03.07Making the most of forage resources
03.07Summary for Hurricane Beryl (AT2/AL022024)
02.07Hurricane Beryl Graphics
02.07Hurricane Beryl Forecast Discussion Number 17
02.07Hurricane Beryl Forecast Advisory Number 17
02.07Ansell Completes Acquisition of Kimberly-Clarks PPE Business
More »